Drug Shortage Report for MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Report ID | 23172 |
Drug Identification Number | 02443902 |
Brand name | MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL |
Common or Proper name | EMTRICITABINE/TENOFOVIR DISOPROXIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE |
Strength(s) | 300MG 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30BT |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-12-19 |
Actual start date | |
Estimated end date | 2019-01-11 |
Actual end date | 2018-12-18 |
Shortage status | Avoided shortage |
Updated date | 2018-12-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v96 | 2018-12-19 | English | Compare |
v95 | 2018-12-12 | French | Compare |
v94 | 2018-12-12 | English | Compare |
v93 | 2018-12-11 | French | Compare |
v92 | 2018-12-11 | English | Compare |
v91 | 2018-12-05 | French | Compare |
v90 | 2018-12-05 | English | Compare |
v89 | 2018-11-21 | English | Compare |
v88 | 2018-11-20 | French | Compare |
v87 | 2018-11-20 | English | Compare |
v86 | 2018-11-13 | French | Compare |
v85 | 2018-11-13 | English | Compare |
v84 | 2018-10-30 | English | Compare |
v83 | 2018-10-29 | French | Compare |
v82 | 2018-10-29 | English | Compare |
v81 | 2018-10-25 | English | Compare |
v80 | 2018-10-23 | French | Compare |
v79 | 2018-10-23 | English | Compare |
v78 | 2018-10-23 | French | Compare |
v77 | 2018-10-23 | English | Compare |